The partnership leverages Shantha Biologics’ specialized infrastructure for sterile fill-finish operations. According to Dr. Vishy Chebrol, director of the company, the arrangement validates their technical capabilities and commitment to international quality standards. While the companies have not disclosed specific financial terms, the agreement mandates strict adherence to established regulatory frameworks throughout the production lifecycle.

Shantha Biologics continues to position itself as a key supplier in the biologics and vaccines sector. By providing dedicated capacity for cartridge filling, the firm aims to support the supply chains of multinational pharmaceutical corporations requiring aseptic manufacturing expertise. The collaboration remains subject to the contractual obligations and compliance protocols governing both organizations.